Zonisamide
CAS: 68291-97-4
Ref. TM-T0267
| 50mg | 52.00 € | ||
| 100mg | 69.00 € | ||
| 200mg | 90.00 € | ||
| 500mg | 134.00 € | ||
| 1ml*10 (DMSO) | 59.00 € |
Product Information
- AD 810, CI 912
Zonisamide (AD 810), a sulfonamide anticonvulsant, is approved for use as an adjunctive treatment in adults with partial-onset seizures. It may inhibit a carbonic anhydrase although this is not one of the main mechanisms of action. Zonisamide may act by blocking repetitive firing of voltage-gated sodium channels results in a reduction of T-type calcium channel currents, or by binding allosterically to GABA receptors. This latter action may lower the uptake of the inhibitory neurotransmitter GABA while increasing the uptake of the excitatory neurotransmitter glutamate.
Chemical properties
Technical inquiry about: TM-T0267 Zonisamide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
